Stock 1345 SHANGHAI PIONEER HOLDING LTD
Add to a list
To use this feature you must be a member
Log inSign up

Financials Shanghai Pioneer Holding Ltd

Equities

1345

KYG2162L1068

Pharmaceuticals

Market Closed - Hong Kong S.E.
Other stock markets
 01:38:22 29/04/2024 pm IST 		5-day change 1st Jan Change
1.9 HKD +1.06% Intraday chart for Shanghai Pioneer Holding Ltd -1.04% +3.83%
24/04 Shanghai Pioneer to Hire New Auditor MT
26/03 Shanghai Pioneer Holding's 2023 Profit Falls as Revenue Stays Flat MT

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 1,117 633.7 987.8 1,646 2,355 1,958
Enterprise Value (EV) 1 1,020 213.9 748.2 1,258 2,104 1,938
P/E ratio 13.2 x 6.04 x 18.7 x 11.5 x 9.97 x 13.5 x
Yield - 6.17% 15.7% 7.28% 3.05% 2.65%
Capitalization / Revenue 0.69 x 0.48 x 0.74 x 1.15 x 1.51 x 1.25 x
EV / Revenue 0.63 x 0.16 x 0.56 x 0.88 x 1.35 x 1.24 x
EV / EBITDA 6.13 x 1.45 x 9.21 x 6.29 x 8.57 x 12.8 x
EV / FCF 17.7 x 0.66 x -64.4 x 5.35 x -49.6 x -11.3 x
FCF Yield 5.67% 152% -1.55% 18.7% -2.02% -8.88%
Price to Book 1.01 x 0.55 x 1.07 x 1.8 x 2.32 x 1.94 x
Nbr of stocks (in thousands) 12,46,797 12,22,487 12,22,487 12,09,689 11,95,771 11,77,171
Reference price 2 0.8956 0.5183 0.8080 1.361 1.969 1.663
Announcement Date 16/04/19 28/04/20 22/04/21 13/04/22 24/04/23 25/04/24
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 1,624 1,316 1,332 1,435 1,556 1,567
EBITDA 1 166.5 147.1 81.22 200 245.4 151
EBIT 1 158.4 138.5 73.12 187.2 232.2 133.5
Operating Margin 9.75% 10.52% 5.49% 13.05% 14.92% 8.52%
Earnings before Tax (EBT) 1 107.1 148.5 95.34 201.4 294.5 180.4
Net income 1 84.6 104.6 52.45 142.6 235.3 145.7
Net margin 5.21% 7.95% 3.94% 9.94% 15.12% 9.3%
EPS 2 0.0677 0.0858 0.0433 0.1186 0.1976 0.1237
Free Cash Flow 1 57.78 325.5 -11.61 235.2 -42.45 -172.1
FCF margin 3.56% 24.73% -0.87% 16.39% -2.73% -10.99%
FCF Conversion (EBITDA) 34.7% 221.2% - 117.63% - -
FCF Conversion (Net income) 68.3% 311.08% - 164.91% - -
Dividend per Share - 0.0320 0.1270 0.0990 0.0600 0.0440
Announcement Date 16/04/19 28/04/20 22/04/21 13/04/22 24/04/23 25/04/24
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 96.7 420 240 388 251 20.4
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 57.8 325 -11.6 235 -42.4 -172
ROE (net income / shareholders' equity) 7.55% 9.23% 5.01% 15.5% 23.8% 12.6%
ROA (Net income/ Total Assets) 6.05% 5.79% 3.07% 8.49% 10% 5.38%
Assets 1 1,398 1,806 1,709 1,680 2,351 2,708
Book Value Per Share 2 0.8900 0.9400 0.7500 0.7600 0.8500 0.8600
Cash Flow per Share 2 0.1200 0.2200 0.1000 0.1900 0.1800 0.1000
Capex 1 0.39 8.89 34 16.6 74.3 30.9
Capex / Sales 0.02% 0.68% 2.55% 1.16% 4.77% 1.97%
Announcement Date 16/04/19 28/04/20 22/04/21 13/04/22 24/04/23 25/04/24
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Pharmaceuticals Wholesale

1st Jan change Capi.
SHANGHAI PIONEER HOLDING LTD Stock Shanghai Pioneer Holding Ltd
+3.83% 282M
MCKESSON CORPORATION Stock McKesson Corporation
+15.91% 71.39B
CARDINAL HEALTH, INC. Stock Cardinal Health, Inc.
+1.89% 25.1B
SINOPHARM GROUP CO. LTD. Stock Sinopharm Group Co. Ltd.
-1.22% 8.59B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD Stock Shanghai Pharmaceuticals Holding Co., Ltd
+7.95% 8.19B
HUADONG MEDICINE CO., LTD Stock Huadong Medicine Co., Ltd
-20.48% 7.91B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD Stock Jointown Pharmaceutical Group Co., Ltd
+15.26% 4.31B
EBOS GROUP LIMITED Stock EBOS Group Limited
-1.24% 3.93B
GALENICA AG Stock Galenica AG
-3.02% 3.86B
CHINA NATIONAL MEDICINES CORPORATION LTD. Stock China National Medicines Corporation Ltd.
+21.10% 3.64B
Pharmaceuticals Wholesale
  1. Stock Market
  2. Equities
  3. 1345 Stock
  4. Financials Shanghai Pioneer Holding Ltd